Profil Financier
Ye Xiaoping occupe actuellement le rang #2380 du classement mondial StarFortune (secteur santé & biotech). Fortune nette estimée : $1.7 B (-$40 sur 24h).
Ye Xiaoping is the chairman of Hangzhou Tigermed Consulting, one of China's largest contract research organizations in the pharmaceutical industry.
Ye holds an EMBA from Peking University and a Ph.D. from Oxford University.
Ye was an executive at Swiss pharmaceutical giant Roche before becoming an entrepreneur.
Tigermed was founded in 2004.